Patents Assigned to NOVEL DRUG SOULTIONS LLC
  • Pharmaceutical ophthalmic compositions
    Patent number: 11684570
    Abstract: Pharmaceutical ophthalmic compositions are described, the compositions consisting essentially of a therapeutically effective quantity of an anti-bacterial agent (such as moxifloxacin), a therapeutically effective quantity of an anti-inflammatory agent (such as prednisolone), a combination of at least two solubilizing and suspending agents (of which one is a non-ionic polyoxyethlene-polyoxypropylene block copolymer), and a carrier. Methods for fabricating the compositions and using them are also described.
    Type: Grant
    Filed: August 11, 2022
    Date of Patent: June 27, 2023
    Assignees: NOVEL DRUG SOULTIONS LLC, EYE CARE NORTHWEST, PA
    Inventors: Jeffrey T. Liegner, John Scott Karolchyk, Bernard Covalesky, Richard Dilzer, Kalian Peters